Qrg Capital Management, Inc. Bio N Tech Se Transaction History

Qrg Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$80.36 - $102.87 $654,934 - $838,390	-8,150 Reduced 48.71%	8,581 $690 Million
Q1 2024 May 07, 2024	BUY	$88.96 - $112.35 $368,650 - $465,578	4,144 Added 32.92%	16,731 $1.54 Billion
Q4 2023 Feb 07, 2024	BUY	$90.91 - $112.75 $406,004 - $503,541	4,466 Added 54.99%	12,587 $1.33 Billion
Q3 2023 Nov 13, 2023	BUY	$98.5 - $125.08 $799,918 - $1.02 Million	8,121 New	8,121 $882 Million

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Qrg Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Qrg Capital Management, Inc. with notifications on news.